Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle loss

Andrew Clark, Subhadip Ghatak, Poornachander Reddy Guda, Mohamed S. El Masry, Yi Xuan, Amy Y. Sato, Teresita Bellido, Chandan K. Sen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

This work rests on our non-viral tissue nanotransfection (TNT) platform to deliver MyoD (TNTMyoD) to injured tissue in vivo. TNTMyoD was performed on skin and successfully induced expression of myogenic factors. TNTMyoD was then used as a therapy 7 days following volumetric muscle loss (VML) of rat tibialis anterior and rescued muscle function. TNTMyoD is promising as VML intervention.

Original languageEnglish
Article number63
Journalnpj Regenerative Medicine
Volume7
Issue number1
DOIs
StatePublished - Dec 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle loss'. Together they form a unique fingerprint.

Cite this